Anopheles mosquito

Anopheles is a genus of mosquito that serves as the primary biological vector for human malaria, caused by Plasmodium parasites (CDC, 2023). While the genus itself is an organism rather than a single molecular target, it is the focus of intense pharmacological and biological intervention to control disease transmission (WHO, 2022). Traditional interventions utilize insecticides like pyrethroids and organophosphates that target the mosquito's nervous system, specifically proteins such as voltage-gated sodium channels and acetylcholinesterase (Soderlund, 2012). Modern research also explores genetic modification and endectocides like ivermectin to reduce mosquito populations or their capacity to transmit pathogens (Chaccour et al., 2013). Understanding the physiological and molecular landscape of Anopheles is essential for overcoming the growing challenge of insecticide resistance in global health (Ranson & Lissenden, 2016).

Other names

Malaria mosquitoAnopheles genus

Interventions targeting Anopheles mosquitoes primarily involve insecticides and endectocides that act on specific molecular targets within the insect, such as voltage-gated sodium channels (pyrethroids/DDT), acetylcholinesterase (organophosphates/carbamates), or glutamate-gated chloride channels (ivermectin), leading to paralysis, death, or reduced transmission capacity (Soderlund, 2012; Chaccour et al., 2013).